| 查看: 656 | 回复: 9 | ||
| 【奖励】 本帖被评价7次，作者nif-hoo增加金币 4.25 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
【分享】Nature-最新文章Lessons from 60 years of pharmaceutical innovation
|
||
|
Nature-最新文章Lessons from 60 years of pharmaceutical innovation 介绍了近60年新药领域之革新。 Abstract | Despite unprecedented investment in pharmaceutical research and development (R&D), the number of new drugs approved by the US Food and Drug Administration (FDA) remains low. To help understand this conundrum, this article investigates the record of pharmaceutical innovation by analysing data on the companies that introduced the ~1,200 new drugs that have been approved by the FDA since 1950. This analysis shows that the new-drug output from pharmaceutical companies in this period has essentially been constant, and remains so despite the attempts to increase it. This suggests that, contrary to common perception, the new-drug output is not depressed, but may simply reflect the limitations of the current R&D model. The implications of these findings and options to achieve sustainability for the pharmaceutical industry are discussed. http://d.namipan.com/d/dd9cc1919a985407d4ddcaacf49b9cf19b4e76c1954e0500 |
回复此楼» 猜你喜欢
论文终于录用啦！满足毕业条件了
已经有13人回复
-
2025年遐想
已经有5人回复
-
投稿Elsevier的杂志（返修），总是在选择OA和subscription界面被踢皮球
已经有8人回复
-
求个博导看看
已经有18人回复
9楼2010-01-17 15:52:23